Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/3058
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
Ronco Claudio.
Reis Thiago.
Acceso Abierto
Atribución-NoComercial-SinDerivadas
10.1038/s41581-020-0284-7
The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19.
Nature Reviews Nephrology
2020
Artículo
https://www.nature.com/articles/s41581-020-0284-7.pdf
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
1103379.pdf443.22 kBAdobe PDFView/Open